锁骨下淋巴结阳性乳腺癌组织雌激素受体、孕激素受体和c-erbB-2的表达分析
被引量:1
摘要
探讨2000~2005年87例乳腺癌改良根治术患者锁骨下淋巴结阳性标本雌激素受体(ER)、孕激素受体(PR)及c-erbB-2的表达情况及临床意义,结果 显示锁骨下淋巴结转移乳腺癌表现出ER、PR的低表达率和c-erbB-2高表达率,为术后综合治疗、准确分期及预后判断提供科学依据。
出处
《中国医师杂志》
CAS
2006年第7期985-985,共1页
Journal of Chinese Physician
二级参考文献13
-
1罗敏,伍贻新,孙佩蓉,张燕,陈家伦.人乳腺癌雌激素受体的免疫组织化学测定[J].中华病理学杂志,1996,25(1):42-43. 被引量:1
-
2张延龄.乳腺癌诊治的进展[J].临床外科杂志,1997,5(1):36-38. 被引量:6
-
3Jerzy K, Christine L, Philippe V, et al. Immunoenzymatic assays of estrogen and proceptors in fine needle and surgical samplesin breast cancer patients[J]. Am J Clin Pathol, 1995,104:289.
-
4Nomura Y, MiuraS, KoyamaH, et al. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer[J]. Cancer, 1992,69:153.
-
5Seaz S. The expression of ER&PR in breast cancer[J]. Recent Results in Cancer Research, 1986,91:129.
-
6Mcguire WL, Tandon AK, Allred DC, et al. Treatment decisions in axillary node-negative breast cancer patients[J]. J Natl Cancer Inst Monogr, 1992,11:173.
-
7Godolphin W, Elwoood JM, Spinelli J J, et al. Estrogen receptor quantitation and staginag as complenentary prognostic indicators in breast cancer:A study of 583 patients[J]. Int J Cancer, 1981,28: 667.
-
8McGuire WL, Clark GM, Dressler LG, et al. Role of steroid hormone receptors as prognostic factors in primary breast cancer [J]. NCI Monoger, 1986,1:19.
-
9Fisher ER, Costanting J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4)[J].Cancer, 1993,71:2141.
-
10中国抗癌协会.新编常见恶性肿瘤诊治规范[M]北京医科大学、中国协和医科大学联合出版社,1999.
共引文献7
-
1余丰文,冯彦林,贺小红,刘德军,温广华,袁建伟.PET-CT与钼靶X线、B超定性诊断乳腺癌的临床对比研究[J].国际放射医学核医学杂志,2006,30(3):148-151. 被引量:9
-
2周才明,黎绍基,何健标.乳腺癌淋巴结转移与ER,PR,Ki67,p53表达的相关分析及临床意义[J].广东医学,2007,28(4):510-512. 被引量:12
-
3王晓春,李靖华,刘耀光.劈开胸大肌乳腺癌改良根治术治疗乳腺癌60例[J].人民军医,2007,50(10):612-612. 被引量:1
-
4冯丹,薄爱华,张彦,吉艳荣.PR与UPA在乳腺癌中的表达及其临床意义[J].现代肿瘤医学,2010,18(3):497-498. 被引量:1
-
5只向成,李树玲,傅西林,黄建英,牛瑞芳.端粒酶在乳腺组织中的表达[J].天津医药,2002,30(10):600-602. 被引量:1
-
6林志武,陈晓耕.乳腺癌锁骨下淋巴结转移在新TNM分期中的意义及其对预后的影响[J].陕西肿瘤医学,2002,10(4):260-261. 被引量:3
-
7张安秦,王颀,林红,施军涛,许娟,李晓伟.早期乳腺癌影像学诊断的评价[J].实用医学杂志,2003,19(4):346-348. 被引量:7
同被引文献18
-
1朱雨岚,刘伟,费娜,吴海威,王维治.雌激素受体存人类垂体腺瘤中的表达[J].中华神经医学杂志,2005,4(4):338-341. 被引量:6
-
2汤宏峰,叶华英,张静,许敬尧.应用免疫组化法检测小儿血管瘤的雌激素受体[J].中华小儿外科杂志,1996,17(3):189-189. 被引量:4
-
3Jensen-Jarolim E, Untersmayr E. Gender-medicine aspects in allergology. Allergy, 2008,63 (5) :610-615.
-
4Lu FX, Abel K, Ma Z, et al. The strength of B cell immunity in female rhesus macaques is controlled by CD8_ T cells under the influ- ence of ovarian steroid hormones. Clin Exp Immunol, 2002,128: 10- 20.
-
5Narita S, Goldblum RM, Watson CS, et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect,2007, 115(1) :48-52.
-
6Zhao XJ, Mckerr G, Dong Z, et al. Repression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax, 2001,56: 205-211.
-
7Molin D , Edstron A , Glimelius I , et al. Mast cell infiltration correlates with poor prognosis in Hodgkins lymphoma. Br J Haematol, 2002, 199: 122-124.
-
8The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J, 2003, 22 : 470-477.
-
9Eliasson O, Scherzer HH, DeGraff AC Jr. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol, 1986,77:87-94.
-
10Oguzulgen IK, Turktas H, Erbas D. Airway inflammation in premenstrual asthma. J Asthma, 2002, 39:517-522.
二级引证文献2
-
1寿小群,屠苗英,孟利青.支气管哮喘患儿T淋巴细胞亚群变化及意义[J].中国基层医药,2011,18(12):1659-1660. 被引量:3
-
2张文强,肖航,熊少斌,李可可,胡君霞,许越淇,严诏琦,刘良徛.基于网络药理学挖掘银翘马勃散治疗喉源性咳嗽的作用机制[J].中医药通报,2023,22(9):52-59. 被引量:1
-
1胡应光.乳腺癌ER、PR、p53、c-erbB-2表达的临床意义[J].中国基层医药,2007,14(6):941-942. 被引量:8
-
2李波,邹扬,胡志军,姚尧,张频,汪昱,郑起.C-erbB-2、p53的联合检测对大肠癌预后的多因素分析[J].山东医药,2009,49(12):18-20. 被引量:1
-
3徐燕,蔡媛,荆娟,马宁,张亚妮,赵斌.荧光原位杂交技术检测胃癌组织中人表皮生长因子受体2基因及其与P53蛋白表达的相关性[J].山西医药杂志,2016,45(8):882-885. 被引量:1
-
4刘国庆.c-erbB_2和p53基因在乳腺癌表达中相关性及其意义[J].陕西医学杂志,2005,34(9):1164-1165. 被引量:1
-
5鲍圣德,浦佩玉,薛庆澄,王燕复,胡自正.脑膜瘤对性激素反应的体外试验[J].中华神经外科杂志,1992,8(1):21-24. 被引量:1
-
6张剑虹,韩永清,张飞,王欣业,白睿,刘博,成日青.乳腺癌组织中c-erbB-2、ER及PR的表达与预后关系的探讨[J].河北北方学院学报(医学版),2009,26(5):57-58.
-
7杨晓辉(综述),李小毛(审校).子宫内膜癌的内分泌治疗进展[J].中国医师杂志,2014,16(2):280-282. 被引量:6
-
8李朝辉,张文,周立中.雌激素受体、孕激素受体表达与乳腺癌新辅助化疗疗效及预后的关系[J].肿瘤研究与临床,2012,24(4):269-271. 被引量:7
-
9朱海滨,李晓婷,王帅,孙应实.体素内不相干运动与直肠腺癌预后病理因素之间的相关性[J].中国医学影像学杂志,2017,25(3):211-215. 被引量:9
-
10陈素钻,俞晶,祝森志,李秋元,张娟,钟敏,荆绪斌,郭光华.胃癌中C—erbB-2和nm23基因的表达及其临床意义[J].中国医师杂志,2009,11(2):170-172.